- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Govt mulls controlling prices of medical equipment
NEW DELHI: The government is considering controlling prices of medical equipment such as stents and implants, Parliament was informed today.
Following a meeting of the Department of Pharmaceuticals with representatives of various manufacturers of medical devices, it was decided that the companies will voluntarily propose a reduction in the marketing expenses of these products and consequentially on the MRP by the first week of December.
This was stated by Minister of State for Chemicals and Fertilizers Hansraj Gangaram Ahir in a reply to a question in Lok Sabha.
The development came after a meeting of Committee of Secretaries was held under the Chairmanship of Cabinet Secretary to discuss mechanism for a separate price control order and a separate vertical within National Pharmaceutical Pricing Authority (NPPA) for medical devices, he added.
Ahir further said that under the plan, all manufacturers of stents/implants were to provide information regarding 'price to retailer' and 'Maximum Retail Price' to NPPA by November 30, 2015.
It was also decided that Department of Pharmaceuticals "may consider issuing a letter to the industry associations to consider voluntary disclosure and self-regulation of marketing expenses," he added.
The meeting also decided that self-regulation by the industry will be reviewed on the basis of information submitted by the industry to NPPA and a decision on statutory regulation will be taken subsequently, Ahir said.
Following a meeting of the Department of Pharmaceuticals with representatives of various manufacturers of medical devices, it was decided that the companies will voluntarily propose a reduction in the marketing expenses of these products and consequentially on the MRP by the first week of December.
This was stated by Minister of State for Chemicals and Fertilizers Hansraj Gangaram Ahir in a reply to a question in Lok Sabha.
The development came after a meeting of Committee of Secretaries was held under the Chairmanship of Cabinet Secretary to discuss mechanism for a separate price control order and a separate vertical within National Pharmaceutical Pricing Authority (NPPA) for medical devices, he added.
Ahir further said that under the plan, all manufacturers of stents/implants were to provide information regarding 'price to retailer' and 'Maximum Retail Price' to NPPA by November 30, 2015.
It was also decided that Department of Pharmaceuticals "may consider issuing a letter to the industry associations to consider voluntary disclosure and self-regulation of marketing expenses," he added.
The meeting also decided that self-regulation by the industry will be reviewed on the basis of information submitted by the industry to NPPA and a decision on statutory regulation will be taken subsequently, Ahir said.
Next Story